PPT-Living with Vasculitis - fatigue management

6 th October 2014 All Ireland Conference on Vasculitis Aoife Synnott Senior Occupational Therapist Rheumatic and Musculoskeletal Disease Unit Harolds Cross Dublin 6W Occupational Therapy. vasculitides. . Dr. . Aditya. . Jindal. 5/8/11. The . vasculitides. are a set of related disorders . characterized by . blood vessel . inflammation . leading to tissue or . end-organ injury. Review of Proposal. Presenter: Jacques R Conaway, MD, FCCP, FAASM. Medical Director, Sleep Center. Member, Emerging Physician Leadership Council. . September 2, 2013. 1. Fatigue Management Program. Prof Philippa Gander PhD, FRSNZ. Dr Karyn O’Keeffe PhD. Outline. Background to the project. Principles. Project Team. Fatigue risk management. Legal requirements. Causes and consequences of fatigue. By: Dr. Donna Braham. Objectives. Classify Vasculitis. Know when to consider Vasculitis. Rule out mimickers of Vasculitis. Diagnose cutaneous small vessel vasculitis – In . particular Henoch–. Schönlein. Takayasu’s arteritis, giant cell arteritis and primary CNS angiitis all have granulomatous angiitis. Takayasu’s arteritis:. This affects the aortic arch, main arterial trunks and descending aorta including the carotid and subclavian arteries. The clinical features of the various . vasculitides. are protean and largely depend on the vascular bed affected (e.g., CNS vs. heart vs. small bowel). . Besides the findings referable to the specific tissues involved, the clinical manifestations typically include constitutional signs and symptoms such as fever, . aortitis. ?. Emily Grodinsky. 11.5.2020. Categorizing vessels by size. More on primary vasculitidities. Even diseases like GCA/. Takayasu. arteritis have significant effects from the smaller vessels (e.g., ophthalmic or retinal arteries in GCA leading to significant morbidity, despite not being “large vessels”). OF AN . INFLAMMATORY CASE. DR NASIR FAROOQ BUTT. ASSISTANT PROFESSOR. DEPARTMENT OF MEDICINE . KING EDWARD MEDICAL UNIVERSITY. MAYO HOSPITAL LAHORE . INVESTIGATIONS . & MANAGEMENT. CASE . SCENARIOS. Signs and symptoms:. 1- . local. :. according. to the involved tissue. 2- . systemic. :(fever, . myalgia. , . arthralgias. , and malaise). Pathogenesis . 1- immune-mediated inflammation. . 2- . infectious pathogens. CABM FIBMS. Internist & Rheumatologist. Large Vessel Vasculitis . Takayasu arteritis. Mikito Takayasu (. 1860.  . - 1938)  . Japanese ophthalmologist. CLINICAL FEATURES . . Diagnosis. . By angiography, which reveals Coarctation, occlusion &aneurysmal dilatation. . Vasculopathy. Fibrinoid deposition, thrombosis with limited to no inflammation.. Infiltration of vessel wall by inflammatory cells with otherwise minimal alteration.. Leukocytoclasis. of tissue infiltrate with minimal alteration of vessel, that is, swelling only, absence of fibrinoid. PRESENTER- Dr. B. PRADEEP.. CHAIR PERSON- Dr. T. SMRUTHI.. Vasculitis are group of disorders characterized by . immunoinflammatory. injury to vessel wall . leading to aneurysm, bleeding, stenosis, occlusion, thrombosis, embolism and ischemia. . Outline. Background to the project. Project aims, processes and outputs. Fatigue is inevitable when 24/7 cover is required. Project aims include evidence-based fatigue risk management . The aim is to work together to implement a new approach. aortitis. ?. Emily Grodinsky. 11.5.2020. Categorizing vessels by size. More on primary vasculitidities. Even diseases like GCA/. Takayasu. arteritis have significant effects from the smaller vessels (e.g., ophthalmic or retinal arteries in GCA...